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Abstract 
Background: Salmonella enterica serovar Enteritidis (S. Enteritidis) is a human and animal pathogen that causes gas-
troenteritis characterized by inflammatory diarrhea and occasionally an invasive systemic infection. Salmonella patho-
genicity islands (SPIs) are horizontally acquired genomic segments known to contribute to Salmonella pathogenesis. 
The objective of the current study was to determine the contribution of SPI-13 to S. Enteritidis pathogenesis.
Methods: We deleted the entire SPI-13 (∆SPI-13) from the genome of S. Enteritidis CDC_2010K_0968 strain isolated 
from a human patient during the 2010 egg-associated outbreak in the US. The kinetics of infection of the wild-type 
parent and the ∆SPI-13 were compared in orally challenged day-old chickens and streptomycin pre-treated mice. The 
degree of intestinal inflammation and the survival of mutant strain within the avian (HD11) and murine (RAW264.7) 
macrophages were also determined.
Results: The deletion of the SPI-13 resulted in impaired infection kinetics of S. Enteritidis in streptomycin pre-treated 
mice which was characterized by significantly lower (P < 0.05) viable counts in the ceca, liver and spleen, impaired 
ability to induce intestinal inflammation and reduced survival within murine macrophages. Conversely, there were 
no significant differences in the infection kinetics of ∆SPI-13 in day-old chickens in any of the organs tested and the 
survival of ∆SPI-13 within chicken macrophages remained unaltered.
Conclusions: The results of this study show that SPI-13 contributes to the pathogenesis of S. Enteritidis in streptomy-
cin pre-treated mice but not in day-old chickens and raises the possibility that SPI-13 may play a role in pathogenesis 
and the host adaptation/restriction of Salmonella serovars.
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Background
Salmonella enterica subspecies enterica serovar Ente-
ritidis (S. Enteritidis) is a major food-borne pathogen 
that causes inflammatory diarrhea in immunocompetent 
patients, however poor immune response or co-infection 
with malaria or HIV may result in invasive infections 
with severe systemic illness [1, 2]. The Salmonella pan-
genome has 23 annotated genomic islands [3, 4] that are 
referred to as Salmonella pathogenicity islands (SPIs). 
Of these, SPI-1 and SPI-2 have been extensively charac-
terized. The current paradigm is that SPI-1 is required 
for invasion of the epithelial cells in the intestinal tract 
whereas SPI-2 is required for survival in macrophages 
and systemic spread (Reviewed in [5]). However, the 
majority of the other SPIs are poorly characterized and 
their contribution to the biology of Salmonella in general 
and pathogenesis in particular remains unclear.
SPI-13 was originally identified in S. Gallinarum (an 
avian host-adapted serotype) by employing a negative 
selection screening approach which has been widely 
used to identify genes that may contribute to in vivo fit-
ness of Salmonella [6]. In this approach, large numbers 
Open Access
Gut Pathogens
*Correspondence:  dshah@vetmed.wsu.edu 
1 Department of Veterinary Microbiology and Pathology, Washington 
State University, Pullman, WA 99164-7040, USA
Full list of author information is available at the end of the article
Page 2 of 12Elder et al. Gut Pathog  (2016) 8:16 
of mutants are pooled and screened for in  vivo fitness 
defects (indicated by loss or lower recovery of a mutant) 
using animal or cell culture models. In the previous study, 
we screened a library of >4000 S. Gallinarum (an avian 
host-adapted serotype) transposon insertion mutants 
in orally challenged day-old chickens and demonstrated 
that mutations within three genes (SG3012, SG3014–
SG3015) resulted in reduced organ colonization and 
competitive defects in vivo [6]. Subsequent mapping and 
bioinformatics analysis of these genes resulted in identi-
fication of SPI-13 (Fig.  1) which includes eighteen open 
reading frames (ORFs) representing a region adjacent to 
tRNA pheV with a G  +  C content (48.1  mol%) signifi-
cantly lower than the mean G + C content (52 mol%) of 
the Salmonella genome.
The sequences downstream of tRNA genes are hot-
spots for recombination in bacteria, it is therefore not 
surprising that SPI-13 appears to have undergone mul-
tiple recombination events in the evolution of the genus 
Salmonella. Evidence of recombination events at this 
locus include insertion/deletion of segments of SPI-13 
resulting in distinct SPI-13 sequences observed between 
S. enterica and S. bongori, as well as differences between 
subspecies and serovars within S. enterica. Salmonella 
bongori shares very few SPI-13 genes with S. Enteritidis 
and strains representing the subspecies indica, salamae, 
diarizonae, arizonae and houtenae also lack many SPI-
13 genes [7]. The differences in gene content between 
S. enterica subspecies could be related to host adapta-
tion as S. enterica subspecies enterica is associated with 
warm-blooded host while S. bongori and the other Sal-
monella subspecies are associated with cold-blooded 
hosts. Interestingly, there are also SPI-13 gene content 
differences within subspecies enterica serovars that seem 
to be related to host adaptation. Serovars Typhi, Para-
typhi A and Sendai, that cause typhoid-like disease and 
are human-adapted, have a different SPI-13 gene com-
position compared to the majority of the non-typhoidal 
Salmonella (NTS) serovars with broad host range [6, 7]. 
Klebseilla pneumoniae and Yersinia pestis have homologs 
to some of the genes in SPI-13 which also suggests that 
SPI-13 is not monophyletic.
Since the original identification of SPI-13 in an avian 
host-adapted S. Gallinarum, few negative selection 
screens have been conducted using non-host restricted 
NTS serovars in which several SPI-13 genes were iden-
tified. Chaudhuri et  al. [8] screened a library contain-
ing pools of >7700 mutants of S. Typhimurium in orally 
infected chickens, pigs, and calves and reported that 
insertion mutations in up to fifteen genes of SPI-13 
resulted in negative selection of these mutants in the 
intestines of these hosts. Moreover, few SPI-13 mutants 
of S. Typhimurium were negatively selected in inter-
nal organs in intra-peritoneally [8, 9] and orally inocu-
lated mice [10]. To date, only one study reported use of 
S. Enteritidis as a model organism in which insertion 
mutations in seven SPI-13 genes (SEN2961–SEN2964, 
SEN2972, SEN2976–SEN2977) resulted in negative 
selection in intra-peritoneally inoculated mice [11]. It is 
important to note that the negative selection of a mutant 
during such large-scale in  vivo screening assays could 
result from number of underlying factors. These include 
direct impact of the mutation on the pathogen-host 
cell interaction or indirectly due to in  vivo competitive 
growth defects or because of impaired metabolic fitness 
or merely due stochastic loss of a mutant from a popu-
lation. Moreover, the negative selection-screening assays 
employed in different studies are often limited to a sin-
gle organ and a single time point and only few have used 
natural route of infection. Thus, although negative selec-
tion of SPI-13 mutants reported in the published studies 
raises a possibility that SPI-13 may have a role in patho-
genesis of Salmonella, this has not been conclusively 
demonstrated.
The specific objective of this study was to directly dem-
onstrate the role of SPI-13 in S. Enteritidis pathogenesis 
by constructing S. Enteritidis mutant lacking the entire 
SPI-13 and determining the effects of absence of SPI-13 
on kinetics of infection (i.e. intestinal colonization and 
invasion, modulation of gut inflammation and inter-
nal organ colonization). To dissect the role of SPI-13 in 
pathogenesis, we used two biologically relevant animal 
models, which included: (1) streptomycin pre-treated 
mouse (an established model for human intestinal 
Fig. 1 Genetic organization of SPI-13 in S. Enteritidis P125109 [13], S. Typhimurium LT2 [34] and S. Gallinarum 287/91 [13]. Gene names are listed for 
P125109 (top, SEN—), LT2 (middle, STM—) and 287/91 (lower, SG—). Bold gene names indicate where transposon mutagenesis has resulted in in vivo 
fitness defects in chickens or mice [6, 8, 11]
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disease) and (2) day-old chickens (the reservoir host and 
a major source of human infection). To the best of our 
knowledge, this is the first study showing the direct evi-
dence that SPI-13 contributes to intestinal pathogenesis 
of S. Enteritidis in streptomycin pre-treated mice. The 
results of this study also point towards the possibility that 
SPI-13 is likely involved in host- adaptation and propa-
gation of S. Enteritidis in gastrointestinal environment of 
mice, but not in chickens.
Methods
Bacterial strains and growth media
The S. Enteritidis CDC_2010K_0968 strain, isolated from 
a human patient in Ohio during the 2010 egg-associated 
outbreak [12], was used as the wild-type (WT) par-
ent strain for constructing following mutants: (1) a k/o 
mutant of SPI-13 (ΔSPI-13), (2) a k/o mutant of SPI-14 
(ΔSPI-14), (3) a k/o mutant of both SPI-13 and SPI-14 
(ΔSPI-13/14) and, (4) a kanamycin resistant derivative 
of the WT strain (WT KanR). The ΔSPI-14 and ΔSPI-
13/14 mutants were included as control strains to com-
pare and confirm the role of SPI-13 in pathogenesis of 
S. Enteritidis in streptomycin pre-treated mouse model 
(see below). The kanamycin resistant derivative of the 
reference strain P125109 (UK KanR) was also included 
for comparison of infection kinetics in streptomycin 
pre-treated mice [13]. The λ-Red recombinase system 
was used to construct ΔSPI-13, ΔSPI-14, ΔSPI-13/14 
and KanR WT strains following procedures described 
previously [14]. For the ΔSPI-13 strain the entire SPI-
13 was replaced with the kanamycin resistance cas-
sette encoded on the pKD4 plasmid amplified with the 
forward primer, SPI13KOFw (5′-TATAAACGGATG 
CGTGATCATAATAAAGGCAGTAATAGTAAGT 
T T TAAC AGTGTAG G C TG GAG C TG C T TC-3 ′ ) , 
and reverse primer, SPI13KORv (5′-CGCTACAGGT 
CAGACGGCGCGGAGCTAATGTTTTTTAACG 
AGGCTTTATCATATGAATATCCTCCTTAG-3 ′). 
The ΔSPI-14 strain was generated by replacement of 
SPI-14 with the kanamycin resistant cassette using 
the forward primer, SPI14KOFw (5′-TTTTAAGATAT 
ATTGAATTATCAGATGCTCCATTCAAATGAGAGA 
CGAGAGTGTAGGCTGGAGCTGCTTC-3′), and the 
reverse primer SPI14KORv (5′-TGCATAACATGGATAA 
AATGGGTAGTCATGCTAGCGAGATAAGACAATGA 
CATATGAATATCCTCCTTAG-3′). The ΔSPI-13/14 
mutant was constructed by replacing SPI-13 in the pre-
viously constructed ΔSPI-14 mutant with the chloram-
phenicol resistance cassette using the primers listed 
above for SPI-13 k/o. For the construction of WT KanR 
and UK KanR strains, the kanamycin resistance cas-
sette was amplified using the forward primer, att_
tn7KOFw (5′-AGCGCAGGTAGGCGTAGCACCTCTT 
AGTCGCTCTTCAGCCACCATAGAGAGTGTAGGCT 
GGAGCTGCTTC-3′), and reverse primer, att_tn7KORv 
(5′-GGCCGTCGATAGACGGCCTTTTTTTGTGCGC 
C GTGAC AG G C G C TGT TC T TATATGA ATATC 
CTCCTTA-3′). This cassette was inserted at the tn7 
attachment site (att_tn7, found between nucleotides 
3,939,373 and 3,939,408) which lies in the intergenic 
region between SEN3674 and glmS in the S. Enteritidis 
strain P125109 genome (NCBI GenBank accession: 
NC_011294). Unless otherwise noted, S. Enteritidis and 
E. coli strains were grown in Luria–Bertani (LB) broth 
(Difco, USA) overnight (16  h) at 37  °C with shaking at 
200  rpm. When appropriate, the medium was supple-
mented with 1.6 % (w/v) Bacto Agar (Difco), carbenicil-
lin (Cb, 100 μg/ml), chloramphenicol (Cm, 20 μg/ml) and 
kanamycin (Km, 50 μg/ml).
Mouse infection experiments
All animal experiments were performed following the pro-
tocols approved by Institutional Animal Care and Usage 
Committee (IACUC). The streptomycin pre-treated mouse 
model was used as previously described [15]. For each 
experiment, 7–8  week-old, female C57BL/6 mice were 
acquired from Harlan laboratories, USA. Food was with-
held for 4  h prior to orogastric administration of 20  mg 
of streptomycin (Sigma Aldrich, USA) in 100 µl of sterile 
H2O. At 24 h post streptomycin treatment, food was with-
held for 4  h. Subsequently, mice were orogastrically chal-
lenged with ~7 log10 CFU WT parent (WT KanR) strain or 
one of the ΔSPI-13, ΔSPI-14, or ΔSPI-13/14 mutant strains. 
At days 5 and 7 post-infection (p.i.), three mice were sacri-
ficed. The liver, spleen, and cecum were collected for direct 
plate counts and section of the cecum was also collected for 
histopathological analysis (see below). Intracellular counts 
in the cecum were determined by washing the tissues 3× 
in sterile PBS to remove as much of the intestinal contents 
and extracellular bacteria as possible and then incubating 
for 30 min at 37 °C with gentamicin (200 µg/ml) to kill any 
remaining extracellular bacteria. The sections were washed 
with sterile PBS to remove residual gentamicin, homog-
enized, then treated with 0.5  % Triton-X 100 to lyse epi-
thelial cells and release intracellular bacteria. Samples from 
the liver, spleen, and cecum were weighed, homogenized 
in sterile maximum recovery diluent (MRD, Difco), serially 
diluted and directly plated on XLT-4 media (Difco) with 
50 μg/ml kanamycin when appropriate. Only in the cases 
when no colonies were recovered from samples by direct 
plating of organ homogenates were samples enriched; 
500 µl of homogenate was used to inoculate 10 ml tetrathi-
onate broth (TTB, Neogen) prepared according to manu-
facturer’s directions. Enrichment cultures were incubated 
at 37 °C for 24 h prior to plating on XLT-4 media followed 
by incubation for 24 h at 37 °C. If TTB enrichment cultures 
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were negative after 24 h, they were plated again at 48 h. If 
a sample was positive after 24 or 48 h of enrichment they 
were assigned the limit of detection for this experiment as 
the lowest CFU/g observed for that specific organ across 
the experiment. If samples were negative at both time 
points 0 CFU/g was assigned for statistical analysis. Organ 
homogenates were directly plated on XLT-4 media (Difco) 
supplemented with 50 μg/ml kanamycin when appropriate. 
Samples found negative by direct plating were enriched as 
described above.
Histological analysis
Cecal sections from mice were embedded in paraffin wax 
and stained with hematoxylin and eosin (H&E). The sec-
tions were analyzed independently by two individuals 
blinded to the sample IDs to assign total inflammation 
scores as described previously with minor modifications 
[15]. Briefly, the score for percent submucosal edema (% 
SE) was calculated from the proportion of the diameter of 
mucosa made up by the space between the tunica muscu-
laris and the epithelial layer using following scores: 0 for 
no detectable edema, 1 for detectable edema (0–10 % of 
the diameter of the cross section of the intestinal mucosa 
and submucosa), 2 for moderate edema (11–40 %), and 3 
for severe edema (>40 %). Infiltration of the lamina propia 
by polymorphonuclear (PMN) cells was scored accord-
ing to number of PMNs in the lamina propia per 10 
high power (400×) fields by using following scores: 0 for 
normal (<5), 1 for slight infiltration (6–20), 2 moderate 
(21–60), 3 for high infiltration (61–100), and 4 for severe 
(>100). Reduction in number of goblet cells were scored 
based on the number of goblet cells per high power field; 
0 for normal (>28), 1 for slight reduction (11–28), 2 for 
moderate reduction (1–10), and 3 for severe reduction 
(<1). Integrity of the intestinal epithelium was scored as 
follows: 0 no detectable loss of integrity, 1 for epithelial 
desquamation, 2 for epithelial erosion and 3 for epithelial 
ulceration. Finally, a total combined score was calculated. 
The combined score of 0 was considered to indicate no 
inflammation, 1, 2 indicated minimal inflammation, 3, 4 
indicated slight inflammation, 5–8 indicated significant 
inflammation, and 9–13 indicated severe inflammation.
Chicken infection experiments
Specific-pathogen-free (SPF) White Leghorn eggs were 
acquired from Sunrise farms (Catskill, NY) and incubated 
for 18  days in the egg incubator (Ova-Easy 190 Advance 
Cabinet Incubator, Brinsea Products Inc, Titusville, FL) 
before transferring to a hatcher (1550 hatcher-GQF, GQF 
manufacturer Co, Savannah, GA) for 3  days following 
manufacturer’s instructions. Newly hatched SPF chicks 
were transferred and housed in HEPA-filtered isolator 
cages. Chickens were orally challenged with 8.5 log10 CFU 
of ΔSPI-13 mutant and the WT parent strain, respectively 
at day-1 of age [16]. Subsequently, four chickens were sacri-
ficed at days-1, 3, 5, 7, 14 and 28 p.i. except on 5 and 28 days 
p.i. when three birds were sacrificed. The spleen, liver, duo-
denum, jejunum, ileum, and ceca were collected for direct 
plate counts. For the determination of viable bacterial 
counts in the small intestine, segments from the duode-
num, jejunum and ileum were pooled for both intracellular 
and total counts. A portion of ceca and each segment of the 
small intestine were processed for determination of intracel-
lular counts similar to as described for mouse experiments.
Intra‑macrophage survival assays
RAW264.7 mouse macrophages (ATCC) were grown in 
D-MEM medium (Gibco, USA) supplemented with 10 % 
fetal bovine serum (FBS, Sigma Aldrich, USA), 2  mM 
l-glutamine, and 20 μg/ml gentamicin at 37  °C with 5 % 
CO2. HD11 chicken macrophages were grown in IMDM 
medium (Gibco, USA) supplemented with 10  % FBS at 
42  °C with 5  % CO2. Gentamicin-protection assays were 
performed as described previously [17]. Briefly, for each 
experiment, RAW264.7 or HD11 cells were seeded in 
three 48-well plates each with 1.25  ×  105 cells per well 
and grown for 16–24  h. Overnight (16  h) cultures of S. 
Enteritidis strains were sub-cultured in fresh LB medium 
and grown for ~3 h at 37 °C with shaking at 200 rpm until 
OD600 of 0.6 was achieved. Bacterial strains were pelleted 
by centrifugation at 13,000g for 2 min, washed three times 
with sterile PBS and resuspended in pre-warmed D-MEM 
(RAW264.7) or IMDM (HD11) to obtain 2.5  ×  106 
CFU/100  μl. Subsequently, 100  μl of each S. Enteritidis 
strain was added to each well (multiplicity of infection of 
~20), infections were synchronized by spinning the plates 
at 250g for 5  min. Cell infection was allowed to proceed 
for 30 min followed by three washings with PBS and gen-
tamicin treatment (200 μg/ml) for 30 min to kill extracel-
lular bacteria. Next, the cells from plate-1 were washed 
3× with sterile PBS and lysed with 0.5  % Triton-X 100. 
The numbers of intracellular bacteria were enumerated 
via direct plate counts which served as a measure of total 
uptake of each bacterial strain. In plate-2 and plate-3, the 
media was replaced with the lower concentration of gen-
tamicin (20 μg/ml) followed by incubation for 2 h (plate-2) 
and 20 h (plate-3). At 2 and 20 h post infection, cells from 
respective plates were processed identically as described 
for plate-1. Percent survival/replication of S. Enteritidis 
strains at 2 and 20 h was determined as follows: CFU at 2 
or 20 h/total uptake CFU × 100. Each strain was tested in 
duplicates in at least three independent experiments.
Statistical analysis
Statistically significant (P  <  0.05) differences in mean 
log10 CFU counts in each organ were determined using 
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Student’s t test for comparing the two means in the pre-
liminary mouse experiments (for determination of dose 
and comparing WT strains) and the chicken experiment. 
A one-way ANOVA with Tukey’s post hoc was used to 
compare means and identify statistically significant dif-
ferences between the four groups in subsequent mouse 
experiment. Mean percent survival in mouse and chicken 
mouse macrophage survival assays were also compared 
using Student’s t test. Mean inflammation score for each 
parameter as wells as mean combined inflammation 
score were compared for the entire experiment using 
two-way ANOVA with Tukey’s post hoc analysis to iden-
tify statistically significant differences (P < 0.05).
Results and discussion
SPI‑13 contributes to colonization of the intestine 
and internal organs, and induction of acute cecal 
inflammation by S. Enteritidis in streptomycin pre‑treated 
mice
NTS infection in the conventional laboratory mice typi-
cally manifests as a systemic disease resembling typhoid 
in humans (Reviewed in [18]). In contrast, pre-treatment 
with high dose of streptomycin (20  mg) 24  h prior to 
infection results in reduced diversity of the microflora 
in the gastrointestinal tract. This in turn, allows Salmo-
nella to extensively colonize the intestinal tract result-
ing in gastro-intestinal disease that closely resembles 
human intestinal disease which is characterized by acute 
gut inflammation and diarrhea (Reviewed in [19]). Thus, 
streptomycin pre-treated mouse model has been exten-
sively characterized and widely adapted as an improved 
model to assess the role of Salmonella genetic factors in 
causing enterocolitis [19].
Most of the published studies have used aminoglyco-
side resistant S. Typhimurium as a model organism and 
have reported that a dose as low as ~2 log10 CFU is suf-
ficient to efficiently colonize streptomycin pre-treated 
mice, however a dose of ~7 log10 CFU has been more 
commonly used [15, 19]. Limited number of studies have 
employed this model to study infection kinetics of ami-
noglycoside resistant S. Enteritidis also reported that 
this model can be used for this serotype as well [15, 20]. 
Because the WT strain (CDC_2010K_0968) used in the 
current study is not naturally resistant to aminoglycoside, 
we constructed an aminoglycoside resistant derivative of 
WT CDC_2010K_0968 strain (WT KanR) by introduc-
ing kanamycin resistance cassette downstream of the tn7 
attachment site (att_tn7, between glmS and SEN3674). 
This genomic site has been previously used for insertion 
of heterologous genes with no adverse effects on in vitro 
or in vivo phenotypes of WT Salmonella strains [21]. As 
expected, the WT KanR strain did not show any pheno-
typic differences when the in vitro growth kinetics were 
compared with the parental WT or with ΔSPI-13, sug-
gesting that insertion of kanamycin cassette did not alter 
in vitro growth characteristics of these strains (data not 
shown). We also compared the kinetics of infection of 
WT KanR strain with that of S. Enteritidis P125109 strain 
(UK KanR) which was originally isolated from a human 
food-borne outbreak in the United Kingdom [13] and 
has been used as a reference strain in published stud-
ies. As expected, both strains colonized cecum to similar 
levels in this model (Fig. 2), suggesting that the kinetics 
of infections of WT KanR strain are comparable to the 
widely used UK KanR as has been described previously 
[15, 20].
Subsequently, we compared the pathogenicity of the 
WT KanR and the ΔSPI-13 mutant. In this experiment, 
we also included ΔSPI-14 and ΔSPI-13/14 mutants that 
were constructed for an unrelated experiment, but served 
as additional controls to compare and confirm the role of 
SPI-13 in pathogenesis. Streptomycin pre-treated mice 
were challenged with ~7 log10 CFU of the WT KanR, 
ΔSPI-13, ΔSPI-14, or ΔSPI-13/14 strain and the kinetics 
of infection were determined on days 5 and 7 p.i. On day 
5 p.i., at least two out of three animals challenged with 
ΔSPI-13 showed lower bacterial counts in the cecum 
and other organs (Fig.  3). This trend was also observed 
in the animals challenged with ΔSPI-13/14 mutant, but 
not the ΔSPI-14 mutant. The effects of absence of SPI-13 
became more evident on day 7 p.i. as the total as well as 
intracellular counts of the ΔSPI-13 as well as ΔSPI-13/14 
mutants in the cecum were significantly (P < 0.05) lower 
Fig. 2 Pilot experiments determined that a dose of 7 log10 CFU 
resulted in optimal cecal colonization (CFU/g) of S. Enteritidis in a 
streptomycin pre-treated mouse model. C57BL/6 mice were infected 
with 7 log10 CFU of the WT Kan
R or UK KanR WT strains. Bars represent 
mean ± SEM of three mice for each time point except for day 7 p.i. 
where only two mice were sacrificed in the UK KanR infected group. 
Significant differences were determined with two-sample t test not 
assuming equal variances (*P < 0.05)
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than the WT KanR. However the kinetics of infection 
with ΔSPI-14 remained similar to WT KanR, suggesting 
that absence of SPI-13 significantly impaired the intesti-
nal colonization and invasion of the intestinal epithelium 
(Fig. 3). Similarly, the counts of ΔSPI-13 and ΔSPI-13/14 
were lower in liver and spleen when compared with the 
WT Kan-R however only the differences in the spleen 
counts were statistically (P  <  0.05) significant (Fig.  3), 
suggesting that ΔSPI-13 mutant was also impaired in its 
ability to colonize internal organs.
In addition to the impaired intestinal and internal 
organ colonization, the combined cecal inflammation 
score, compromised of the sum of the indidivual scores 
for percent edema, infiltration of PMNs, loss of goblet 
cells, and epithelial integrity, was significantly (P < 0.05) 
lower on days 5 and 7 p.i. among animal groups infected 
with ΔSPI-13 and ΔSPI-13/14 mutant when compared 
with WT Kan-R, but the inflammation scores were not 
significantly different in animals challenged with ΔSPI-14 
mutant (Figs. 4, 5). By day 7 p.i., the inflammation score 
for the WT Kan-R and ΔSPI-14 challenged groups were 
significantly higher than mock infected control (Fig.  4). 
In contrast, the inflammation scores for the ΔSPI-13 
and ΔSPI-13/14 challenged groups were not significantly 
different from the mock-infected controls (Fig.  4). Col-
lectively, these data show that absence of SPI-13 results 
in the reduced intestinal and internal organ coloniza-
tion and significantly reduced intestinal inflammation in 
streptomycin pre-treated mice. Additionally, infection 
kinetics of ΔSPI-13/14 were similar to ΔSPI-13 whereas 
infection kinetics of ΔSPI-14 were similar to the WT 
Kan-R further confirming that SPI-13 indeed contributes 
to the pathogenesis of S. Enteritidis in streptomycin pre-
treated mice.
SPI‑13 contributes to survival in mouse macrophages
Uptake by and survival/replication within the host mac-
rophages is a critical step for Salmonella to colonize 
the internal organs of hosts. Salmonella is specifically 
adapted to the intracellular niche and survives within 
Fig. 3 Deletion of SPI-13 but not SPI-14 results in impaired colonization of the cecum (a), reduced invasion of the intestinal epithelium (b), and 
impaired colonization of the liver (c) and spleen (d). Bars represent mean ± SEM of three mice for each time point except for day 7 p.i. where in the 
ΔSPI-13/14 infected group where mean intracellular cecal counts from two animals were used. Significant differences were determined using a 
one-way ANOVA with Tukey’s post hoc for multiple comparisons (*P < 0.05)
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macrophages by avoiding phago-lysosomal fusion 
through formation of the Salmonella containing vacu-
ole (SCV). Infected macrophages then act as vehicle 
and transport Salmonella to the internal organs via the 
circulatory system. Therefore we tested the survival of 
the ΔSPI-13 mutant in mouse macrophages as this may 
relate to the reduced internal organ colonization shown 
in Fig.  3. Intra-macrophage survival assay showed that 
the ΔSPI-13 mutant (39.4 %) was more readily phagocy-
tosed when compared with WT KanR (2.9 %). Moreover, 
the survival/replication rate of ΔSPI-13 (57.3  %) at 2  h 
p.i. was significantly (P < 0.05) lower than the WT KanR 
(609.6 %). Similarly, ΔSPI-13 (2.4 %) showed significantly 
(P  <  0.05) lower survival at 20  h when compared with 
the WT KanR (24.3  %) (Fig.  6). These data corroborate 
with the previous report showing that deletion of a first 
gene of SPI-13 (STM3117) in S. Typhimurium resulted 
in impaired survival in murine macrophages [22]. Addi-
tionally, it has been previously reported that expression 
of several SPI-13 genes is upregulated in S. Typhimu-
rium during intra-macrophage infection [23, 24]. There-
fore, our data corroborates with the previous reports and 
shows that SPI-13 contributes to the intra-macrophage 
survival of S. Enteritidis. Thus, decreased colonization of 
internal organs by the ΔSPI-13 mutant could, in part, be 
attributed to its decreased systemic dissemination due to 
impaired survival in macrophages. Interestingly, deletion 
of ripABC operon, which is homologous to SEN2961–
SEN2963, in Y. pestis is also associated with decreased 
survival in mouse macrophages [25], further suggesting 
that SPI-13 is important for efficient replication in intra-
cellular environment of phagocytic cells. However, the 
reports of potential mechanisms underlying for intra-
macrophage survival are contradictory. Torres and oth-
ers [26] postulated that rip operon of Y. pestis is likely 
responsible for production of butyrate, a molecule that 
has anti-inflammatory properties. These authors sug-
gested that butyrate reduces the production of nitric 
oxide by macrophages and thereby enhances intra-mac-
rophage survival of Y. pestis. In contrast, a more recent 
biochemical characterization of Rip proteins of Y. pestis 
showed that these proteins are more likely involved in 
degradation of itaconate [27]. Itaconate is is produced by 
macrophages in response to immune responsive gene 1 
(IRG1) expression and recognized as a potent antimicro-
bial which inhibits the glyoxylate cycle of bacteria [28]. 
We performed bioinformatics analysis of SPI-13 genes 
and found that the first ten genes in SPI-13 (SEN2960–
SEN2969) are predicted to encode putative proteins that 
are likely involved in the metabolism of aromatic mon-
oamines or related molecules such as itaconate and the 
last gene (SEN2977) is a putative hexuronate transporter 
Fig. 4 Deletion of SPI-13 but not SPI-14 results in reduced cecal inflammation in orally infected mice. Bars represent mean inflammation severity 
score ± SEM from three mice for each time point with the contribution from individual parameters indicated. Significant differences were deter-
mined using Tukey’s post hoc analysis of two-way ANOVA (NS not significant; **P < 0.01; ***P < 0.001; ****P < 0.0001)
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which is likely involved in uptake or hexuronate, sug-
gesting that SPI-13 is likely involved in metabolism of 
multiple metabolic substrates. Although intriguing, it 
is currently unknown which of these metabolic mecha-
nisms play an active role during S. Enteritidis infection 
in intestinal and intracellular environment in mice. More 
research is needed to improve our mechanistic under-
standing of role of SPI-13 in Salmonella metabolism and 
in particular its link to intestinal infection and intra-mac-
rophage survival of S. Enteritidis.
Salmonella Enteritidis SPI‑13 does not significantly 
impair the intestinal colonization and organ colonization 
in chickens
We were particularly interested in the contribution of 
SPI-13 to the pathogenesis in chickens because poul-
try and poultry products have been implicated as the 
primary vehicles for the transmission of S. Enteritidis 
to people [29, 30]. Therefore, we infected two groups of 
24, 1-day-old chickens with ~8.5 log10 CFU of the WT 
parent or the ΔSPI-13 mutant strain and determined 
the kinetics of infection in the liver, spleen, cecum, and 
small intestine up to 28  days p.i. The results revealed 
that the total and intracellular counts in both cecum and 
small intestine of chickens infected with ΔSPI-13 were 
not significantly different from the WT infected chick-
ens (Fig.  7). Note that on day 1 p.i., sample-processing 
error resulted in residual gentamicin in the small intes-
tinal samples from chickens challenged with WT result-
ing in the killing of the bacteria released after cell lysis 
and subsequent negative isolation results. Similarly, we 
found no significant differences in the colonization of 
spleen and liver between ΔSPI-13 mutant and WT par-
ent strain (Fig. 7). Interestingly, two chickens challenged 
with WT strain died during the course of experiment (1 
on day-1 p.i. and 1 on day-4 p.i.); however no mortality 
was observed in chickens inoculated with the ΔSPI-13 
mutant strain. Collectively, the results show that absence 
of SPI-13 did not significantly impair the ability of S. 
Enteritidis to colonize the intestine and internal organs 
Fig. 5 The WT KanR strain produces severe inflammation of the 
cecum characterized by epithelial erosion and necrosis (er), infiltration 
of PMNs (p), edema (e), and a reduction in the number of goblet 
cells (g) whereas the ΔSPI-13 mutant produces mild or more similar 
to the level of inflammation observed with mock-infected controls. 
Representative H&E stained cecal cross-sections are shown from each 
group on days 5 and 7 p.i. Scale bar indicates 100 μm. L lumen
Fig. 6 Deletion of SPI-13 results in increased uptake and reduced 
survival (2 and 20 h) in mouse RAW264.7 macrophages. Bars 
represent mean percent of each phenotype from three biological 
replicates ± SEM. Significant differences were determined using two-
sample t test not assuming equal variances (*P < 0.05)
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of chickens, however the difference in mortality raises 
a possibility that absence of SPI-13 may have resulted 
in subtle reduction of virulence of S. Enteritidis in day-
old chickens. Determination of the LD50 of the ΔSPI-
13 mutant will be needed to confirm and conclusively 
demonstrate these differences in virulence in chicken. 
Noteworthy is that our results contradict the previous 
report in which S. Typhimurium mutants with insertion 
mutations within several SPI-13 genes were negatively 
selected in orally inoculated chickens [8]. There are mul-
tiple plausible explanations for this discrepancy. First, we 
employed individual strain infections whereas Chaudhuri 
et  al. [8] employed mixed infection approach in which 
reduced competitive fitness of the mutants could result 
in their negative selection. It is also possible that SPI-
13 mutants reported by Chaudhuri et  al. [8] could rep-
resent false positives because a high false discovery rate 
of negatively selected mutants was reported by these 
authors. Serotype differences could also contribute to 
discrepancies between our results and previous studies 
because S. Typhimurium and S. Enteritidis differ in their 
repertoire of pathogenicity factors [11, 31]. The apparent 
role of SPI-13 in metabolism could also explain the dif-
ference in phenotypes observed in SPI-13 mutants of S. 
Enteritidis in this study and S. Gallinarum in our previ-
ous study [6]. Salmonella Gallinarum is known to have 
more pseudogenes than S. Enteritidis and several of the 
genes encoding metabolic functions are degraded in this 
host-adapted serotype making this serotype metaboli-
cally auxotrophic [13]. Consequently, it is possible that 
SPI-13 genes partly fulfil the metabolic requirements of 
S. Gallinarum in chicken host and therefore its absence 
may adversely affect infectivity of S. Gallinarum in chick-
ens, but does not affect infectivity of metabolically more 
Fig. 7 Deletion of SPI-13 does not significantly impact pathogenesis of S. Enteritidis in chickens. One-day-old chickens were orally infected with 
8.5 log10 CFU of WT (black bars) or ΔSPI-13 mutant (gray bars). Mean total log10 CFU/g of tissue in the cecum (a), small intestine (b), liver (c), spleen 
(d), and mean intracellular log10 CFU/g of both strains in the cecum (e) and small intestine (f). Each time point represents the mean + SEM of four 
chickens. Significant differences (P < 0.05) were identified using two-sample t test not assuming equal variance for each time point
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efficient S. Enteritidis in the same host. Further biochem-
ical characterization of ΔSPI-13 will be required to iden-
tify exact target metabolic substrates for genes encoded 
on this island. Research is also needed to determine the 
potential role of such metabolic substrates in vivo during 
Salmonella infection streptomycin pre-treated mouse.
SPI‑13 does not contribute to the survival of S. Enteritidis 
in chicken macrophages
Previously, transposon insertion mutation in SEN2961 
was reported to result in impaired intra-cellular survival 
of S. Enteritidis in avian macrophages [32]. Consequently, 
we tested the intra-macrophage survival of the ΔSPI-13 
mutant strain and compared with the WT parent strain 
using chicken macrophage-like cells (HD11). Interest-
ingly, the uptake (30 min) of ΔSPI-13 in HD-11 cells was 
higher than its WT counterpart (Fig. 8). However, in con-
trast to the previous report [32], the intracellular survival 
of ΔSPI-13 mutant was similar to WT at early (2 h) and 
slightly higher than WT at late (20 h) intracellular phase 
(Fig.  8). These data suggest that the absence of SPI-13 
does not result in impaired intra-macrophage survival of 
S. Enteritidis.
Conclusions
In summary, our results show that SPI-13 contributes 
to the pathogenesis of S. Enteritidis which is character-
ized by decreased colonization of the cecum, reduced 
inflammation and reduced colonization of the spleen and 
liver in streptomycin pre-treated mice. The decreased 
colonization may be at least in part due to the decreased 
survival in murine macrophages that could limit dis-
semination to the internal organs. In contrast, we did 
not observe significant difference in the pathogenesis of 
ΔSPI-13 mutant in chicken host and there was no defect 
in the growth and/or survival of the mutant in chicken 
macrophages. These data raise several interesting ques-
tions why SPI-13 is required for full virulence of S. Enter-
itidis in murine host, but does not appear to be imporant 
in its reservoir host, chickens? Is it is likely that SPI-13 
is a host-specific pathogenicity island? and if true, is this 
host-specificity is linked to the potential role of SPI-13 in 
S. Enteritidis metabolism which may impact metabolic 
fitness of S. Enteritidis in specific hosts? It is intriguing 
because broad-host range Salmonella serovars are known 
to have diverse metabolism to support optimal growth in 
potentially nutrient-limited conditions encountered in 
different hosts or in the external environment [33]. One 
plausible hypothesis is that SPI-13 may be important for 
S. Enteritidis’s ability to utilize monoamines and/or hexu-
ronates in hosts such as streptomycin pre-treated mouse 
where these nutrients may serve as primary source of 
energy in  vivo. In contrast, this nutrient demand of S. 
Enteritidis in chicken host is compensated with other 
sources making SPI-13 dispensable in this reservoir host.
Finally, several Salmonella serovars such as Typhi, 
Paratyphi A and Sendai and at least few NTS serotypes, 
have a different SPI-13 gene composition compared to 
the majority of the other NTS serovars with broad host 
range [6, 7]. More specifically, the first six genes within 
SPI-13 are completely absent in S. Typhi and S. Paraty-
phi whereas S. Seftenberg and S. Infantis have large inser-
tions at the upstream end of SPI-13. This suggest that 
SPI-13 has a modular architechture [6, 7]. However it is 
currently unknown if this genetic diversity within SPI-13 
also contributes to differential virulence of Salmonella in 
different hosts and if it is associated with differential of 
metabolic dependence of Salmonella in different hosts. 
The modular architechture of SPI-13 is intriguing. We 
chose to use the most inclusive description of SPI-13 for 
defining SPI-13 in the current study. However, work is in 
progress to more rigorously define the island and deter-
mine which genes within this island specifically contrib-
ute to the pathogenesis and metabolism of S. Enteritidis.
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